You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Digoxin and mortality in atrial fibrillation: a prospective cohort study
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, August 2007
|
| DOI | 10.1007/s00228-007-0346-9 |
| Pubmed ID | |
| Authors |
Pär Hallberg, Johan Lindbäck, Bertil Lindahl, Ulf Stenestrand, Håkan Melhus, for the RIKS-HIA group |
| Abstract |
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study showed that rhythm-control treatment of patients with atrial fibrillation (AF) offered no survival advantage over a rate-control strategy. In a subgroup analysis of that study, it was found that digoxin increased the death rate [relative risk (RR) = 1.42), but it was suggested that this may have been attributable to prescription of digoxin for patients at greater risk of death, such as those with congestive heart failure (CHF). No study has investigated a priori the effect of digoxin on mortality in patients with AF. This study aimed to address this question. |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| United States | 1 | 1% |
| Denmark | 1 | 1% |
| Unknown | 93 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 17% |
| Student > Bachelor | 14 | 15% |
| Student > Ph. D. Student | 13 | 14% |
| Student > Master | 10 | 10% |
| Other | 9 | 9% |
| Other | 17 | 18% |
| Unknown | 17 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 57 | 59% |
| Agricultural and Biological Sciences | 5 | 5% |
| Mathematics | 3 | 3% |
| Chemistry | 3 | 3% |
| Nursing and Health Professions | 2 | 2% |
| Other | 8 | 8% |
| Unknown | 18 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2020.
All research outputs
#3,525,716
of 26,017,215 outputs
Outputs from European Journal of Clinical Pharmacology
#297
of 2,829 outputs
Outputs of similar age
#8,583
of 79,460 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#1
of 13 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,829 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 79,460 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.